These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6851372)

  • 1. Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration.
    Pisani F; Richens A
    Clin Pharmacokinet; 1983; 8(3):272-6. PubMed ID: 6851372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugs.
    Cottrell PR; Streete JM; Berry DJ; Schäfer H; Pisani F; Perucca E; Richens A
    Epilepsia; 1982 Jun; 23(3):307-13. PubMed ID: 7084140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.
    Nau H; Rating D; Häuser I; Jäger E; Koch S; Helge H
    Eur J Clin Pharmacol; 1980 Jul; 18(1):31-42. PubMed ID: 7398746
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-dose kinetics of primidone in human subjects: effect of phenytoin on formation and elimination of active metabolites of primidone, phenobarbital and phenylethylmalonamide.
    Sato J; Sekizawa Y; Yoshida A; Owada E; Sakuta N; Yoshihara M; Goto T; Kobayashi Y; Ito K
    J Pharmacobiodyn; 1992 Sep; 15(9):467-72. PubMed ID: 1287181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of phenylethylmalonamide (PEMA) in elderly men.
    Streete JM; Berry DJ; Newberry JE; Crome P
    Eur J Clin Pharmacol; 1987; 33(4):431-4. PubMed ID: 3443150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of primidone and its metabolites, phenylethylmalonamide and phenobarbital, in the dog.
    Yeary RA
    Am J Vet Res; 1980 Oct; 41(10):1643-5. PubMed ID: 7224290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylethylmalonamide serum levels in patients treated with primidone and the effects of other antiepileptic drugs.
    Streete JM; Berry DJ; Pettit LI; Newbery JE
    Ther Drug Monit; 1986; 8(2):161-5. PubMed ID: 3088778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of primidone in elderly patients.
    Martines C; Gatti G; Sasso E; Calzetti S; Perucca E
    Br J Clin Pharmacol; 1990 Oct; 30(4):607-11. PubMed ID: 2291873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of phenylethylmalonamide during haemodialysis of a patient with renal failure.
    Streete JM; Berry DJ; Jones JA; Groggin MJ
    Ther Drug Monit; 1990 May; 12(3):281-3. PubMed ID: 2349613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of primidone, phenylethylmalonamide, and phenobarbital in the rabbit.
    Hunt RJ; Miller KW
    Drug Metab Dispos; 1978; 6(1):75-81. PubMed ID: 23277
    [No Abstract]   [Full Text] [Related]  

  • 11. Primidone, phenobarbital, and PEMA: I. Seizure protection, neurotoxicity, and therapeutic index of individual compounds in mice.
    Bourgeois BF; Dodson WE; Ferrendelli JA
    Neurology; 1983 Mar; 33(3):283-90. PubMed ID: 6681871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic serum concentrations of primidone and its metabolites, phenobarbital and phenylethylmalonamide in epileptic dogs.
    Cunningham JG; Haidukewych D; Jensen HA
    J Am Vet Med Assoc; 1983 May; 182(10):1091-4. PubMed ID: 6863121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose pharmacokinetics and anticonvulsant efficacy of primidone in mice.
    Leal KW; Rapport RL; Wilensky AJ; Friel PN
    Ann Neurol; 1979 May; 5(5):470-4. PubMed ID: 464548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylethylmalonamide (PEMA). An important metabolite of primidone.
    Baumel IP; Gallagher BB; Mattson RH
    Arch Neurol; 1972 Jul; 27(1):34-41. PubMed ID: 4626105
    [No Abstract]   [Full Text] [Related]  

  • 15. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood and cerebrospinal fluid pharmacokinetics of primidone and its primary pharmacologically active metabolites, phenobarbital and phenylethylmalonamide in the rat.
    Nagaki S; Ratnaraj N; Patsalos PN
    Eur J Drug Metab Pharmacokinet; 1999; 24(3):255-64. PubMed ID: 10716065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma level studies of primidone and its metabolites in the mouse at various stages of pregnancy.
    McElhatton PR; Sullivan FM; Toseland PA
    Xenobiotica; 1977 Oct; 7(10):617-22. PubMed ID: 910462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible phenylethylmalondiamide (PEMA) intoxication.
    Stern EL
    Ann Neurol; 1977 Oct; 2(4):356-7. PubMed ID: 617272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of primidone, phenobarbital and phenylethylmalonamide in the stimulated frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1984 Jan; 228(1):121-7. PubMed ID: 6607337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant effect of primidone in the gerbil. Time course and significance of the active metabolites.
    Frey HH; Löscher W; Reiche R; Schultz D
    Pharmacology; 1984; 28(6):329-35. PubMed ID: 6728906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.